GIP receptor agonism appears to amplify weight loss beyond what GLP-1 alone achieves, which is part of why dual agonists like tirzepatide outperform semaglutide in head-to-head comparisons
Chen YF, Liu H, Luo XJ, Zhao Z, Zou ZY, Li J, Lin XJ, Liang Y
Part of it comes down to the science: GLP-1 weight loss medications address the biological drivers of hunger, not just willpower
Each serving delivers 78 billion CFUs from a broad range of beneficial strains including Lactobacillus, Bifidobacterium, Akkermansia muciniphila and Christensenella minuta, known for their contribution to a balanced gut microbiome
You shouldnt get BR+ NAD therapy if youre experiencing acute withdrawal (which usually happens within the first week of quitting a substance), if youre pregnant or breastfeeding, or if you have certain health conditions, including: a known allergy to NAD products or IV drip ingredients severe liver, kidney, or heart disease active cancer active infection G6PD deficiency For more information, talk to your healthcare provider
Doctor Examination There is no single test or finding that confirms rheumatoid arthritis, so doctors use results from a patients health history, a physical examination, and several laboratory tests to rule out other conditions and make a diagnosis
